Diabetic Kidney Disease - Clinical Study [US,CA] (Email,Social,Banner,Native,Push,SEO,Search,Brand Bidding) - CPL | oDigger
Join the Community
Top Networks
Top Categories
    Top Searches

      Diabetic Kidney Disease - Clinical Study [US,CA] (Email,Social,Banner,Native,Push,SEO,Search,Brand Bidding) - CPL

      Promote this offer through the SmartAdv Affiliate Network

      Offer Details:


      Offer Name:

      Diabetic Kidney Disease - Clinical Study [US,CA] (Email,Social,Banner,Native,Push,SEO,Search,Brand Bidding) - CPL

      Preview:

      Preview Landing Page

      Categories:

      Health

      Network:

      SmartAdv

      Status:

      Active

      Last Updated:

      Nov 21, 2024

      Date Added:

      Nov 21, 2024

      Payouts:

      $100.00 / cpa

      Countries:

      		 US / CA
      Join SmartAdv

      Affiliate Offer Description:

      You must be a member of SmartAdv to promote this offer. Click Here to join their network.
      Conversion Point: Valid Form Fill Age Range: 30-80 Gender: All GEO: US Only Traffic Allowed: Email, Social, Banner, Native, Push, SEO, Search, Brand Bidding No Incent No Co-Reg No Survey No SMS No Adult Send ad creatives and LP to AM for approval Forbidden traffic types/false Advertisements Will NOT Be Paid For Fake/false celebrity ads/endorsements are strictly prohibited Qualifications: Diagnosed with Type 2 Diabetes Cannot be receiving dialysis Cannot have a history of heart or liver failure Cannot be on blood thinners Diabetic kidney disease (diabetic nephropathy) is a common complication of type 1 and type 2 diabetes. Over time, poorly controlled diabetes can cause damage to blood vessel clusters in your kidneys that filter waste from your blood. This can lead to kidney damage and cause high blood pressure. Study Description: The purpose of this clinical study is to see how effective an investigational injectable cell therapy is at helping to treat diabetic kidney disease. You may be asked to attend a screening visit to determine if you are eligible to enroll in the study. If enrolled, you will be randomly assigned to one of two groups. One group will undergo a kidney biopsy. The study team will prepare the investigational product from the biopsy tissue. You will then receive one injection of your own highly concentrated kidney cells into each kidney, three months apart. The second group will undergo simulated procedures for the biopsy and the injections, meaning that the procedure will be mimicked, but no actual tissue is extracted and reinjected. You will not know which group you are in while participating in the study. Your total participation may last up to 5 years. You will be asked to attend 16 office visits in the first 6 months and then follow-up visits every 3 months until the study ends. During these visits, you will complete various procedures, diagnostic and laboratory tests. The doctor’s office conducting the study will be able to provide you with more information about the study requirements.
      SmartAdv

      About: SmartAdv

      SmartAdv prides itself on service and support as our state of the art infrastructure operates 24/7/365 and our account managers are at your beck and c ... Read More

      SmartAdv prides itself on service and support as our state of the art infrastructure operates 24/7/365 and our account managers are at your beck and call to provide concierge service to all of our customers. Get incredible offers to monetize websites and campaigns, in addition to generating high click-through and sales ratios, not to mention excellent payouts and terms.

      Build traffic in popular verticals and increase your profitability. We work with you to setup and maintain your solutions so you can focus on your business and increase your profits, without wasting time on technology.

      Join the industry's premier network and come grow with us!
      Read Less

      Similar offers

      var AdButler = AdButler || {}; AdButler.ads = AdButler.ads || []; var abkw = window.abkw || ''; var plc378612 = window.plc378612 || 0; var plc378614 = window.plc378614 || 0; var plc378613 = window.plc378613 || 0; var plc389895 = window.plc389895 || 0; var plc389896 = window.plc389896 || 0; var plc389897 = window.plc389897 || 0; var plc389898 = window.plc389898 || 0; var plc389899 = window.plc389899 || 0; var plc389900 = window.plc389900 || 0; var plc378615 = window.plc378615 || 0; var plc378616 = window.plc378616 || 0; var plc378623 = window.plc378623 || 0; var masterObject = { topAd: { id: 378612, counter: plc378612 }, homepageAd2: { id: 378614, counter: plc378614 }, sidebarTopAd: { id: 378613, counter: plc378613 }, sidebarAd1: { id: 389895, counter: plc389895 }, sidebarAd2: { id: 389896, counter: plc389896 }, sidebarAd3: { id: 389897, counter: plc389897 }, sidebarAd4: { id: 389898, counter: plc389898 }, sidebarAd5: { id: 389899, counter: plc389899 }, sidebarAd6: { id: 389900, counter: plc389900 }, sidebarBottomAd: { id: 378615, counter: plc378615 }, bottomAd: { id: 378616, counter: plc378616 }, offerTopAd: { id: 378623, disabled: false, counter: plc378623 } }; Object.keys(masterObject).forEach(function(key) { var entry = masterObject[key]; var element = document.getElementById(key); if (element && !entry.disabled) { document.getElementById(key).innerHTML = `
      `; AdButler.ads.push({ handler: function(opt) { AdButler.register( 161318, entry.id, [728,90], 'placement_' + entry.id + '_' + opt.place, opt ) }, opt: { place: entry.counter++, keywords: abkw, domain: 'servedbyadbutler.com', click: 'CLICK_MACRO_PLACEHOLDER' } }); } });